SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-05-000201
Filing Date
2005-01-18
Accepted
2005-01-18 16:15:06
Documents
3
Period of Report
2005-01-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b53013aie8vk.htm 8-K 13494
2 EX-99.1 PRESS RELEASE DATED JANUARY 18, 2005 b53013aiexv99w1.htm EX-99.1 3861
3 EX-99.2 RISK FACTORS b53013aiexv99w2.htm EX-99.2 72357
  Complete submission text file 0000950135-05-000201.txt   91605
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 05533972
SIC: 2836 Biological Products, (No Diagnostic Substances)